Home
About Us
Our Company
Our Challenge
Our Mission
ATXA Team
Board of Directors
Corporate Information
PAH-HOPE
News & Events
News
Posters & Publications
Careers
Contact Us
More
Seasons Greetings from ATXA
Post not marked as liked
Recent Posts
Seasons Greetings from ATXA
Newly-published preclinical findings for ATXA Therapeutics' NTP42
World Orphan Drug Virtual Conference
Jonathan Langley Appointment
ATXA Therapeutics looks to raise $30m to secure regulatory approval
Publication of preclinical findings for ATXA Therapeutics' NTP42
Seasons Greetings from ATXA
100 Hot Start Ups.
ATXA & PAH- Hope attend ERS Congress 2019 in Madrid
ATXA attends the ESC Congress 2019 in Paris
Archive
December 2020
(1)
1 post
October 2020
(1)
1 post
August 2020
(2)
2 posts
July 2020
(1)
1 post
April 2020
(1)
1 post
December 2019
(1)
1 post
September 2019
(3)
3 posts
August 2019
(1)
1 post
July 2019
(2)
2 posts
May 2019
(8)
8 posts
April 2019
(1)
1 post
March 2019
(1)
1 post
February 2019
(5)
5 posts
January 2019
(1)
1 post
November 2018
(2)
2 posts
October 2018
(1)
1 post
September 2018
(1)
1 post
May 2018
(2)
2 posts
April 2018
(1)
1 post
March 2018
(1)
1 post
February 2018
(2)
2 posts
Search By Tags
ATXA
FDA
NTP42
